Reprint
Polymeric Carriers for Biomedical and Nanomedicine Application
Edited by
June 2021
186 pages
- ISBN978-3-0365-1173-3 (Hardback)
- ISBN978-3-0365-1172-6 (PDF)
This is a Reprint of the Special Issue Polymeric Carriers for Biomedical and Nanomedicine Application that was published in
Chemistry & Materials Science
Engineering
Summary
This book focuses on the design of polymeric delivery systems for biomedical and nanomedicine applications as well as on understanding how such biomaterials interact in the physiological environment. The reader will find an encompassing view on the state-of-the-art of polymeric carriers, showing how current research deals with new stimuli-responsive systems for cancer therapies and biomedical challenges, namely overcoming the skin barrier. The published papers cover topics ranging from novel production methods and insights on hybrid polymers to applications as diverse as nanoparticles, hydrogels and microneedles for antifungal skin therapy, peptide and siRNA delivery, enhanced skin absorption of bioactive molecules, and anticancer therapy. The book comprises one review paper and nine research papers.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
osteoarthritis; monosodium iodoacetate; p47phox; PLGA nanoparticles; reactive oxygen species; full factorial design; optimization; metronidazole; nanocomposites; sodium alginate; chitosan; PLGA; chitosan; hybrid polymers; chitosan-PLGA polymer; NMR; DSC; FT-IR; covalent drug conjugation; therapeutic nanodevice; polymeric nanoparticles; cancer therapy; controlled drug delivery; redox responsive PEG-block-PLA; nanocarriers; disulfide bond; controlled release; retinol; nanosponge; hydrogel; Box–Behnken design; pharmacokinetic; terbinafine hydrogel; niacinamide; polyethene glycol (PEG) 400; solvent; dermal delivery; finite dose; porcine skin; dissolving microneedles; multiple sclerosis; PLP; transdermal delivery; PLGA; tyrosol; nanoparticles; Design of Experiment (DoE); chitosan; β cyclodextrin; DNA binding; glyconanoparticles; immunotherapy; infectious diseases; mannose receptors; nutraceuticals; n/a